文献速递头颈部肿瘤放疗

电子老年评估与头颈部癌症老年患者接受辅助放疗和化疗的相关性

Correlation of an Electronic Geriatric Assessment With Receipt of Adjuvant Radiation and Chemotherapy in Older Adults With Head and Neck Cancer.
PubMed 文献 · Adv Radiat Oncol · 2022-10-04

本研究回顾性分析了73例完成电子快速体能评估(eRFA)后接受治疗的头颈部鳞状细胞癌老年患者,评估累积老年缺陷(AGD)评分与辅助放化疗接受情况的相关性。结果显示,接受辅助化疗的患者中位AGD评分显著低于未接受者(3 vs 6;P=0.044),而辅助放疗的接受与AGD评分、年龄及体能状态均无关。在17例新诊断且切缘阳性或结外扩展的患者中,仅9例接受辅助放疗,仅3例接受全身治疗。

要点

  • 接受辅助化疗者中位AGD评分显著低于未接受者(3 vs 6;P=0.044)。
  • 辅助放疗的接受与AGD评分、年龄及体能状态均无关联。
  • 17例切缘阳性或结外扩展的新诊断患者中,仅9例接受辅助放疗,仅3例接受全身治疗。

核心结论

  • 接受辅助化疗与衰弱程度相关,化疗使用率非常低,表明需要新策略以减轻该患者群体的毒性负担。
  • 接受辅助放疗与衰弱程度无关,但接受放疗者中观察到衰弱程度较低的趋势。

研究设计与样本

  • 回顾性综述,纳入完成新型老年评估(电子快速体能评估,eRFA)后接受治疗的73例头颈部鳞状细胞癌老年患者,其中56例(77%)为口腔癌。
  • eRFA产生累积老年缺陷(AGD)评分,评分越高表示衰弱程度越高;比较指标为年龄和体能状态。
  • 采用Wilcoxon秩和检验比较接受与未接受辅助放疗和化疗者之间的差异。

主要发现

  • 最常见的老年缺陷为主要痛苦、社交活动受限、抑郁和日常生活活动能力受损。
  • AGD评分、年龄和体能状态与接受辅助放疗无关。
  • 接受辅助化疗者的中位AGD评分显著低于未接受者(3 vs 6;P=0.044),但年龄和体能状态与化疗接受无关。
  • 17例新诊断且切缘阳性或结外扩展的患者中,仅9例接受辅助放疗,仅3例接受全身治疗;全身治疗最常因患者偏好、合并症和体能状态差而被省略。
  • 接受与未接受标准分次放疗的患者之间AGD评分较低但差异未达统计学显著(中位4 vs 6.5;P=0.13)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Treatment patterns for head and neck squamous cell carcinoma (HNSCC) vary among older adults because of concerns about their health status. Geriatric assessment may guide treatment for older adults with HNSCC by assessing their health status. METHODS AND MATERIALS: We conducted a retrospective review of adjuvant treatment received by older patients with HNSCC who completed a novel geriatric assessment, the electronic Rapid Fitness Assessment, before treatment. The electronic Rapid Fitness Assessment yields an accumulated geriatric deficits (AGD) score. Higher AGD score indicates greater frailty. Comparators were age and performance status. The Wilcoxon rank sum test compared differences between those who did and did not receive adjuvant radiation therapy and chemotherapy. RESULTS: The cohort included 73 patients, of whom 56 (77%) had oral cavity cancer. The most common geriatric deficits were major distress, social activity limitation, depression, and impaired activities of daily living. AGD score, age, and performance status were not associated with receipt of adjuvant radiation. Patients who received adjuvant chemotherapy had a significantly lower median AGD score than those who did not (3 vs 6; P = .044), but there was no association with age and performance status. Of the 17 patients with newly diagnosed disease and either positive margins or extranodal extension, only 9 received adjuvant radiation and only 3 received systemic therapy. Most often, systemic therapy was omitted because of patient preference or comorbidities and poor performance status. There was a nonstatistically significant lower AGD score between patients who did and did not receive standard fractionated radiation therapy (median, 4 vs 6.5; P = .13). CONCLUSIONS: Receipt of adjuvant chemotherapy was associated with frailty. Rates of chemotherapy utilization were very low, indicating the need for novel strategies to mitigate the toxicity burden in this patient population. Receipt of adjuvant radiation therapy was not associated with frailty; however, there was a trend toward lower frailty among those who did receive radiation therapy.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Restifo D, Raab G, McBride SM, et al. Correlation of an Electronic Geriatric Assessment With Receipt of Adjuvant Radiation and Chemotherapy in Older Adults With Head and Neck Cancer. Adv Radiat Oncol. 2022. PMID: 36483055. doi:10.1016/j.adro.2022.101096

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。